These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35273142)

  • 1. Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity.
    Hu L; Salmen W; Chen R; Zhou Y; Neill F; Crowe JE; Atmar RL; Estes MK; Prasad BVV
    Nat Commun; 2022 Mar; 13(1):1241. PubMed ID: 35273142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous expression of human norovirus GII.4 VP1 leads to assembly of T=4 virus-like particles.
    Devant JM; Hofhaus G; Bhella D; Hansman GS
    Antiviral Res; 2019 Aug; 168():175-182. PubMed ID: 31145925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
    Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
    Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity.
    Salmen W; Hu L; Bok M; Chaimongkol N; Ettayebi K; Sosnovtsev SV; Soni K; Ayyar BV; Shanker S; Neill FH; Sankaran B; Atmar RL; Estes MK; Green KY; Parreño V; Prasad BVV
    Nat Commun; 2023 Oct; 14(1):6516. PubMed ID: 37845211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.
    Parra GI; Abente EJ; Sandoval-Jaime C; Sosnovtsev SV; Bok K; Green KY
    J Virol; 2012 Jul; 86(13):7414-26. PubMed ID: 22532688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
    Koromyslova AD; Morozov VA; Hefele L; Hansman GS
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epochal coevolution of minor capsid protein in norovirus GII.4 variants with major capsid protein based on their interactions over the last five decades.
    Hong X; Xue L; Gao J; Jiang Y; Kou X
    Virus Res; 2022 Oct; 319():198860. PubMed ID: 35817094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.
    Kocher J; Bui T; Giri-Rachman E; Wen K; Li G; Yang X; Liu F; Tan M; Xia M; Zhong W; Jiang X; Yuan L
    J Virol; 2014 Sep; 88(17):9728-43. PubMed ID: 24920797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains.
    Tohma K; Lepore CJ; Gao Y; Ford-Siltz LA; Parra GI
    mBio; 2019 Sep; 10(5):. PubMed ID: 31551337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and physico-chemical characterization of human norovirus-like particles under various environmental conditions.
    Abou-Hamad N; Estienney M; Chassagnon R; Bon M; Daval-Frerot P; de Rougemont A; Guyot S; Bouyer F; Belliot G
    Colloids Surf B Biointerfaces; 2023 Nov; 231():113545. PubMed ID: 37741147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics and asymmetry in the dimer of the norovirus major capsid protein.
    Tubiana T; Boulard Y; Bressanelli S
    PLoS One; 2017; 12(7):e0182056. PubMed ID: 28750021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of GII.4 norovirus persistence in human populations.
    Lindesmith LC; Donaldson EF; Lobue AD; Cannon JL; Zheng DP; Vinje J; Baric RS
    PLoS Med; 2008 Feb; 5(2):e31. PubMed ID: 18271619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
    Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
    PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution cryo-EM structures of outbreak strain human norovirus shells reveal size variations.
    Jung J; Grant T; Thomas DR; Diehnelt CW; Grigorieff N; Joshua-Tor L
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12828-12832. PubMed ID: 31182604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobody binding to a conserved epitope promotes norovirus particle disassembly.
    Koromyslova AD; Hansman GS
    J Virol; 2015 Mar; 89(5):2718-30. PubMed ID: 25520510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China.
    Huo Y; Zheng L; Chen X; Ge L; Wang Y
    Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor profile and immunogenicity of the non-epidemic norovirus GII.8 variant.
    Gao J; Xue L; Liang Y; Wang L; He F; Meng L; Cai W; Zhang J; Wang J; Ye Q; Wu S; Gu Q; Wu Q
    Virus Res; 2021 Dec; 306():198603. PubMed ID: 34662679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finger printing human norovirus-like particles by capillary isoelectric focusing with whole column imaging detection.
    Du J; Wu G; Cui C; Yu C; Cui Y; Guo L; Liu Y; Liu Y; Wang W; Liu C; Fu Z; Li M; Guo S; Yu X; Yang Y; Duan M; Xu G; Wang L
    Virus Res; 2022 Apr; 311():198700. PubMed ID: 35093475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomic Structure of the Murine Norovirus Protruding Domain and Soluble CD300lf Receptor Complex.
    Kilic T; Koromyslova A; Malak V; Hansman GS
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.